Jonathan Rende, Chief Research & Development Officer at CASTLIGHT HEALTH, INC. (CSLT), sold 7,794 shares at $4.99 ($39K) on 2016-11-16, disclosed to the SEC on 2016-11-17.
Open-market sale of $39k CSLT by Chief Research & Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CSLT | SELL | 2016-05-17 | $205K | — | Filing → |